Clinical Safety and Effectiveness of a Swallowable Gas-filled Intragastric Balloon System for Weight Loss: Consecutively Treated Patients in the Initial Year of US Commercialization

Recently, endoscopic bariatric therapies, including intragastric balloons, have emerged as treatment options with the potential to fill the unmet need of patients who have obesity, but are currently undertreated [1]. Intragastric balloons have less weight loss than bariatric surgery but are approved by the Food and Drug Administration (FDA) for use in lower Body Mass Index (BMI) categories and some without the requirement for an obesity-related co-morbidity [2-7]. Providing options in addition to weight loss surgery may increase overall obesity treatment rates.

Source: Surgery for Obesity and Related Diseases - December 7, 2018 Category: Surgery Authors: Rachel L. Moore, Michael V. Seger, Shawn M. Garber, Adam B. Smith, Richard T. Nguyen, Moses K. Shieh, Robert G. Snow, Shelby Sullivan Tags: Original articles Source Type: research